Well, I am hoping that this snafu over clarification on the Phase 2 trial gets resolved. I think that is the main reason we are below $4. I think if it gets resolved and if the company announced it ( unclear if they would) we might head back over $4 and maybe if the stars are aligned and maybe $5+ is possible again.
News 
Market Data 
Discover 
